Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 2, 2014, Pages 399-405

  Bradshaw, Tyler J ^a   Yip, Stephen ^a   Jallow, Ngoneh ^a   Forrest, Lisa J ^b   Jeraj, Robert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; SPATIAL DISTRIBUTION;

BIOLOGICAL PROPERTIES; CORRELATION COEFFICIENT; METHODS AND MATERIALS; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; PROLIFERATIVE ACTIVITY; SPATIOTEMPORAL STABILITY; SPEARMAN CORRELATION COEFFICIENTS; STANDARDIZED UPTAKE VALUES;

TUMORS;

3' FLUOROTHYMIDINE F 18; COPPER(II) DIACETYL BIS(N4 METHYLTHIOSEMICARBAZONE); RADIOPHARMACEUTICAL AGENT; SEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER RADIOTHERAPY; CELL PROLIFERATION; CHONDROSARCOMA; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DNA DAMAGE CHECKPOINT; EQUIPMENT FAILURE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; OSTEOSARCOMA; PARANASAL SINUS TUMOR; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TOMOTHERAPY; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL PROLIFERATION; CHONDROSARCOMA; DIDEOXYNUCLEOSIDES; DOG DISEASES; DOGS; DOSE FRACTIONATION; MULTIMODAL IMAGING; NOSE NEOPLASMS; ORGANOMETALLIC COMPOUNDS; OSTEOSARCOMA; PARANASAL SINUS NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; THIOSEMICARBAZONES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899896340     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.02.016     Document Type: Article

References (32)

1. K.S. Chao, G. Ozyigit, and B.N. Tran et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer Int J Radiat Oncol Biol Phys 55 2003 312 321
2. D. Pucar, H. Hricak, and A. Shukla-Dave et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence Int J Radiat Oncol Biol Phys 69 2007 62 69
3. C.C. Ling, J. Humm, and S. Larson et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
4. E.J. Hall, and A.J. Giaccia Radiobiology for the Radiologist 6th ed. 2006 Lippincott Williams & Wilkins Philadelphia
5. M. Nordsmark, M. Overgaard, and J. Overgaard Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 1996 31 39
6. K.A. Krohn, J.M. Link, and R.P. Mason Molecular imaging of hypoxia J Nucl Med 49 Suppl 2 2008 129S 148S
7. D. Thorwarth, S.M. Eschmann, and F. Paulsen et al. Hypoxia dose painting by numbers: A planning study Int J Radiat Oncol Biol Phys 68 2007 291 300
8. K.S. Chao, W.R. Bosch, and S. Mutic et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 2001 1171 1182
9. A. Sovik, E. Malinen, and O.S. Bruland et al. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study Phys Med Biol 52 2007 499 513
10. D. Thorwarth, and M. Alber Implementation of hypoxia imaging into treatment planning and delivery Radiother Oncol 97 2010 172 175
11. S.M. Bentzen Theragnostic imaging for radiation oncology: Dose-painting by numbers Lancet Oncol 6 2005 112 117
12. M.W. Dewhirst, Y. Cao, and B. Moeller Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response Nat Rev Cancer 8 2008 425 437
13. S. Roels, P. Slagmolen, and J. Nuyts et al. Biological image-guided radiotherapy in rectal cancer: Is there a role for FMISO or FLT, next to FDG? Acta Oncol 47 2008 1237 1248
14. S.A. Nehmeh, N.Y. Lee, and H. Schroder et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer Int J Radiat Oncol Biol Phys 70 2008 235 242
15. Z. Lin, J. Mechalakos, and S. Nehmeh et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography Int J Radiat Oncol Biol Phys 70 2008 1219 1228
16. S. Okamoto, T. Shiga, and K. Yasuda et al. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer J Nucl Med 54 2013 201 207
17. J.J. Kim, and I.F. Tannock Repopulation of cancer cells during therapy: An important cause of treatment failure Nat Rev Cancer 5 2005 516 525
18. 8fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study Radiother Oncol 98 2011 109 116
19. J. Yue, L. Chen, and A.R. Cabrera et al. Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: A pilot clinical study J Nucl Med 51 2010 528 534
20. S. Everitt, R.J. Hicks, and D. Ball et al. Imaging cellular proliferation during chemo-radiotherapy: A pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 75 2009 1098 1104
21. E.G. Troost, J. Bussink, and A.L. Hoffmann et al. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors J Nucl Med 51 2010 866 874
22. L.N. Kubicek, S. Seo, R.J. Chappell, R. Jeraj, and L.J. Forrest Helical tomotherapy setup variations in canine nasal tumor patients immobilized with a bite block Vet Radiol Ultrasound 53 2012 474 481
23. D. Yang, S. Brame, and I. El Naqa et al. Technical note: DIRART - A software suite for deformable image registration and adaptive radiotherapy research Med Phys 38 2011 67 77
24. K.C. McCall, D.L. Barbee, M.W. Kissick, and R. Jeraj PET imaging for the quantification of biologically heterogeneous tumours: Measuring the effect of relative position on image-based quantification of dose-painting targets Phys Med Biol 55 2010 2789 2806
25. M.J. Nyflot, P.M. Harari, S. Yip, S.B. Perlman, and R. Jeraj Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx Radiother Oncol 105 2012 36 40
26. T.J. Bradshaw, S.R. Bowen, N. Jallow, L.J. Forrest, and R. Jeraj Heterogeneity in intratumor correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in canine sinonasal tumors J Nucl Med 54 2013 1931 1937
27. R. Murata, Y. Shibamoto, and K. Sasai et al. Reoxygenation after single irradiation in rodent tumors of different types and sizes Int J Radiat Oncol Biol Phys 34 1996 859 865
28. G. Iliakis, Y. Wang, and J. Guan et al. DNA damage checkpoint control in cells exposed to ionizing radiation Oncogene 22 2003 5834 5847
29. V. Kersemans, B. Cornelissen, and R. Hueting et al. Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation PLoS One 6 2011 e25911
30. K. Hansen, and C. Khanna Spontaneous and genetically engineered animal models: use in preclinical cancer drug development Eur J Cancer 40 2004 858 880
31. J.R. Dilworth, and R. Hueting Metal complexes of thiosemicarbazones for imaging and therapy Inorganica Chimica Acta 389 2012 3 15
32. J.A. O'Donoghue, P. Zanzonico, and A. Pugachev et al. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl- bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models Int J Radiat Oncol Biol Phys 61 2005 1493 1502